These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17666312)

  • 41. Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.
    Gonsalez CR; Alcalde R; Nishiya A; Barreto CC; Silva FE; de Almeida A; Mendonça M; Ferreira F; Fernandes SS; Casseb J; Duarte AJ
    Virus Res; 2007 Nov; 129(2):87-90. PubMed ID: 17686543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Available clinical markers of treatment outcome integrated in mathematical models to guide therapy in HIV infection.
    Vergu E; Mallet A; Golmard JL
    J Antimicrob Chemother; 2004 Feb; 53(2):140-3. PubMed ID: 14688052
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Computational models for prediction of response to antiretroviral therapies.
    Prosperi MC; De Luca A
    AIDS Rev; 2012; 14(2):145-53. PubMed ID: 22627610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modeling the short-, middle- and long-term viral load responses for comparing estimated dynamic parameters.
    Huang Y
    Biom J; 2007 Jun; 49(3):429-40. PubMed ID: 17623347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Learning from past treatments and their outcome improves prediction of in vivo response to anti-HIV therapy.
    Saigo H; Altmann A; Bogojeska J; Müller F; Nowozin S; Lengauer T
    Stat Appl Genet Mol Biol; 2011; 10():Article 6. PubMed ID: 21291416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dealing with sparse data in predicting outcomes of HIV combination therapies.
    Bogojeska J; Bickel S; Altmann A; Lengauer T
    Bioinformatics; 2010 Sep; 26(17):2085-92. PubMed ID: 20624779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rate and predictors of optimal virologic response to antiretroviral therapy in Colombia.
    Diazgranados CA; Silva A; Bermudez A; Roncancio D; Diruggiero P; Mantilla M
    Int J Infect Dis; 2007 Nov; 11(6):531-5. PubMed ID: 17512234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interpreting resistance data for HIV-1 therapy management--know the limitations.
    Van Laethem K; Vandamme AM
    AIDS Rev; 2006; 8(1):37-43. PubMed ID: 16736950
    [TBL] [Abstract][Full Text] [Related]  

  • 49. HIV cohort collaborations: proposal for harmonization of data exchange.
    Kjaer J; Ledergerber B
    Antivir Ther; 2004 Aug; 9(4):631-3. PubMed ID: 15456095
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiretroviral drug development: the challenge of cost and access.
    Dunne M
    AIDS; 2007 Jul; 21 Suppl 4():S73-9. PubMed ID: 17620756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incorporating durability information in the comparison of proportions of patients with HIV suppression.
    Chen YH; Nessly ML; Thiyagarajan B
    J Biopharm Stat; 2004 Aug; 14(3):741-55. PubMed ID: 15468762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Scaled marginal models for multiple continuous outcomes.
    Roy J; Lin X; Ryan LM
    Biostatistics; 2003 Jul; 4(3):371-83. PubMed ID: 12925505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.
    Frentz D; Boucher CA; Assel M; De Luca A; Fabbiani M; Incardona F; Libin P; Manca N; Müller V; O Nualláin B; Paredes R; Prosperi M; Quiros-Roldan E; Ruiz L; Sloot PM; Torti C; Vandamme AM; Van Laethem K; Zazzi M; van de Vijver DA
    PLoS One; 2010 Jul; 5(7):e11505. PubMed ID: 20634893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Success of root canal therapy in HIV-positive patients.
    Shetty K; Garcia J; Leigh J
    Gen Dent; 2006; 54(6):397-402. PubMed ID: 17134076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experience with high success rate of antiretroviral therapy in elderly HIV-infected patients.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Vibhagool A
    Age Ageing; 2004 Sep; 33(5):520-1. PubMed ID: 15315930
    [No Abstract]   [Full Text] [Related]  

  • 56. The individualized genetic barrier predicts treatment response in a large cohort of HIV-1 infected patients.
    Beerenwinkel N; Montazeri H; Schuhmacher H; Knupfer P; von Wyl V; Furrer H; Battegay M; Hirschel B; Cavassini M; Vernazza P; Bernasconi E; Yerly S; Böni J; Klimkait T; Cellerai C; Günthard HF;
    PLoS Comput Biol; 2013; 9(8):e1003203. PubMed ID: 24009493
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational methods for the design of effective therapies against drug resistant HIV strains.
    Beerenwinkel N; Sing T; Lengauer T; Rahnenführer J; Roomp K; Savenkov I; Fischer R; Hoffmann D; Selbig J; Korn K; Walter H; Berg T; Braun P; Fätkenheuer G; Oette M; Rockstroh J; Kupfer B; Kaiser R; Däumer M
    Bioinformatics; 2005 Nov; 21(21):3943-50. PubMed ID: 16144807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis.
    Viala M; Bhakar AL; de la Loge C; van de Velde H; Esseltine D; Chang M; Dhawan R; Dubois D
    J Clin Epidemiol; 2007 Jul; 60(7):670-679. PubMed ID: 17573982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimating probit models with self-selected treatments.
    Bhattacharya J; Goldman D; McCaffrey D
    Stat Med; 2006 Feb; 25(3):389-413. PubMed ID: 16382420
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Excellent outcomes of cardiac surgery in patients infected with HIV in the current era.
    Filsoufi F; Salzberg SP; Harbou KT; Neibart E; Adams DH
    Clin Infect Dis; 2006 Aug; 43(4):532-6. PubMed ID: 16838245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.